TrialBritish journal of cancer2009

A phase I-II study of the histone deacetylase inhibitor valproic acid plus chemoimmunotherapy in patients with advanced melanoma.

A Rocca et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.